| Combination antiretroviral therapy and the risk of myocardial infarction Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group New England Journal of Medicine 349 (21), 1993-2003, 2003 | 2103 | 2003 |
| Decline in the AIDS and death rates in the EuroSIDA study: an observational study A Mocroft, B Ledergerber, C Katlama, O Kirk, P Reiss, AA Monforte, ... The Lancet 362 (9377), 22-29, 2003 | 1635 | 2003 |
| Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study Data Collection on Adverse Events of Anti-HIV Drugs Study Group Archives of internal medicine 166 (15), 1632-1641, 2006 | 1488 | 2006 |
| Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration D: A: D Study Group The Lancet 371 (9622), 1417-1426, 2008 | 1159 | 2008 |
| Trends in underlying causes of death in people with HIV from 1999 to 2011 (D: A: D): a multicohort collaboration CJ Smith, L Ryom, R Weber, P Morlat, C Pradier, P Reiss, JD Kowalska, ... The Lancet 384 (9939), 241-248, 2014 | 1113 | 2014 |
| Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients AA Monforte, AC Lepri, G Rezza, P Pezzotti, A Antinori, AN Phillips, ... Aids 14 (5), 499-507, 2000 | 761 | 2000 |
| Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort D Konopnicki, A Mocroft, S De Wit, F Antunes, B Ledergerber, C Katlama, ... Aids 19 (6), 593-601, 2005 | 732 | 2005 |
| AIDS across Europe, 1994–98: the EuroSIDA study A Mocroft, C Katlama, AM Johnson, C Pradier, F Antunes, F Mulcahy, ... The Lancet 356 (9226), 291-296, 2000 | 639 | 2000 |
| Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients A Mocroft, O Kirk, P Reiss, S De Wit, D Sedlacek, M Beniowski, J Gatell, ... Aids 24 (11), 1667-1678, 2010 | 522 | 2010 |
| Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study N Friis-Møller, R Thiebaut, P Reiss, R Weber, A D'Arminio Monforte, ... European journal of cardiovascular prevention & rehabilitation 17 (5), 491-501, 2010 | 437 | 2010 |
| Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study A Mocroft, R Brettle, O Kirk, A Blaxhult, JM Parkin, F Antunes, P Francioli, ... Aids 16 (12), 1663-1671, 2002 | 414 | 2002 |
| Association Between Antiretroviral Exposure and Renal Impairment Among HIV-Positive Persons With Normal Baseline Renal Function: the D:A:D Studya L Ryom, A Mocroft, O Kirk, SW Worm, DA Kamara, P Reiss, M Ross, ... The Journal of infectious diseases 207 (9), 1359-1369, 2013 | 369 | 2013 |
| Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study. LJD m L, Mocroft A, Kirk O, Worm SW, Kamara DA, Reiss P, Ross M, Fux CA ... J Infect Dis 207 (9), 1359-69, 2013 | 369 | 2013 |
| Serious fatal and nonfatal non-AIDS-defining illnesses in Europe A Mocroft, P Reiss, J Gasiorowski, B Ledergerber, J Kowalska, A Chiesi, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 55 (2), 262-270, 2010 | 338 | 2010 |
| Influence of age on CD4 cell recovery in human immunodeficiency virus–infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study JP Viard, A Mocroft, A Chiesi, O Kirk, B Røge, G Panos, N Vetter, ... The Journal of infectious diseases 183 (8), 1290-1294, 2001 | 319 | 2001 |
| Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America Antiretroviral Therapy Cohort Collaboration Clinical Infectious Diseases 41 (12), 1772-1782, 2005 | 286 | 2005 |
| One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects M Airoldi, M Zaccarelli, L Bisi, T Bini, A Antinori, C Mussini, F Bai, ... Patient preference and adherence, 115-125, 2010 | 261 | 2010 |
| Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study JP Viard, JC Souberbielle, O Kirk, J Reekie, B Knysz, M Losso, J Gatell, ... Aids 25 (10), 1305-1315, 2011 | 246 | 2011 |
| Risk factors for overdose mortality: a case-control study within a cohort of intravenous drug users M DAVOLI, CA PERUCCI, F FORASTIERE, PAT DOYLE, E RAPITI, ... International Journal of Epidemiology 22 (2), 273-277, 1993 | 185 | 1993 |
| A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival A Mocroft, S Madge, AM Johnson, A Lazzarin, N Clumeck, FD Goebel, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 22 (4), 369-378, 1999 | 184 | 1999 |
Federica ForbiciSpecialista in Microbiologia e VirologiaVerified email at inmi.it
